EACS 2017: New European Guidelines Cover HIV, Hepatitis C, and Related Conditions
- Details
- Category: HIV Treatment
- Published on Thursday, 30 November 2017 00:00
- Written by Keith Alcorn
Everyone with HIV and hepatitis C virus (HCV) coinfection should receive direct-acting antiviral therapy for hepatitis C and should receive the same treatment regimens for hepatitis C as people with HCV monoinfection, new European guidelines issued at the 16th European AIDS Conference recommend.
EACS 2017: Fostemsavir Controls Viral Load in Half of People with Highly Drug-Resistant HIV
- Details
- Category: HIV Treatment
- Published on Thursday, 30 November 2017 00:00
- Written by Keith Alcorn
Fostemsavir, a new experimental attachment inhibitor, suppressed viral load in over half of participants with extensive drug resistance when added to a background regimen selected by resistance testing, Max Lataillade of ViiV Healthcare reported at the recent 16th European AIDS Conference in Milan.
EACS 2017: Up to a Quarter of HIV-Negative Gay Men Attending 3 English Clinics Used PrEP in the Last Year
- Details
- Category: HIV Prevention
- Published on Tuesday, 14 November 2017 00:00
- Written by Gus Cairns
A prospective cohort study of gay men attending 3 clinics in southern England --56 Dean Street and Mortimer Market Centre in London and the Brighton & Hove SHAC (Sexual Health & Contraception) service -- have found that 23% of HIV-negative service users who responded to a follow-up questionnaire had used PrEP (pre-exposure prophylaxis) in the last year. These interim results from the AURAH2 study were presented recently at the 16th European AIDS Conference (EACS 2017) in Milan.
EACS 2017: European Cure Review Concentrates on HIV Therapeutic Vaccines
- Details
- Category: Search for a Cure
- Published on Friday, 17 November 2017 00:00
- Written by Gus Cairns
A cure for HIV would almost inevitably have to involve a vaccine to improve the body’s natural ability to control HIV, speakers said at a recent seminar on European HIV cure research. The STEPS seminar, put on by the European AIDS Treatment Group (EATG) ahead of the European AIDS Conference in Milan in October, also heard that, in the words of EATG member and European Community Advisory Board chair Giulio Maria Corbelli, "Cure research reminds us of the importance of patient involvement from the very earliest phases of the development of treatment and prevention."
Coverage of the 16th European AIDS Conference
- Details
- Category: HIV Treatment
- Published on Tuesday, 14 November 2017 00:00
- Written by HIVandHepatitis.com
HIVandHepatitis.com and NAM coverage of the 16th European AIDS Conference (EACS 2017), October 25-27 2017, in Milan.
More Articles...
- EACS 2017: HIV Diagnoses in English Gay Men Have Been Falling Since 2014
- EACS 2017: High HIV Incidence from Non-Primary Partners and Low PEP and PrEP Use Seen in PARTNER Study
- EACS 2017: European AIDS Clinical Society Strengthens HPV Vaccination Advice
- EACS 2017: Swiss Study Examines When Gay Men Decided to Stop Consistent Condom Use
- EACS 2017: Survey of Dating App Users Finds that PrEP Usage Has Not Increased in Europe in the Last Year
- EACS 2017: Boosted Protease Inhibitor + Lamivudine Effective for HIV Maintenance Treatment
- EACS 2017: Hepatitis C Halved among Spanish People with HIV Thanks to HCV Treatment
- EACS 2017: ABX464 Reduces HIV Reservoir But Does Not Delay Vial Rebound
- EACS 2017: Test-and-Treat Reduces HCV Among Gay Men in Swiss HIV Cohort
- EACS 2017: High Rate of Hepatitis C Reinfection in German Men Who Have Sex With Men
- EACS 2017: Symtuza as Effective as Multi-Pill Combination in Previously Untreated People with HIV
- EACS 2017: How a London Clinic Reduced New HIV Infections by 90%
Web Design and Development by